Pharma lobby wielded "inordinate amount of influence" over EU during pandemic
A new critical report says the EU Commission submitted to vaccine makers’ demands for prices, transparency, and IP rights during the pandemic crisis.
by andreas lønstrup, translated by daniel pedersen
The pharmaceutical lobby’s influence on European institutions and the EU Parliament increased markedly during the pandemic, affecting health of EU residents, reports Euractiv citing a new report from Global Health Advocates (GHA) and Stopaids.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Pfizer to quadruple Covid-19 vaccine price in US
For subscribers
